迈得医疗2025年度归母净利润6525.99万元

Core Viewpoint - Maide Medical (688310.SH) reported a significant increase in revenue and net profit for the fiscal year 2025, indicating a successful operational strategy and market demand for its products [1] Financial Performance - The company achieved an operating revenue of 447 million yuan, representing a year-on-year increase of 62.79% [1] - The net profit attributable to the parent company was 65.26 million yuan, with a net profit of 53.29 million yuan after deducting non-recurring gains and losses, marking a substantial turnaround from previous losses [1] Business Development - The overall revenue growth was driven by the orderly implementation of production plans, ensuring effective product delivery [1] - The company emphasized technological innovation and process iteration, which strengthened product competitiveness and market influence [1] - The blood purification and drug-device combination intelligent equipment businesses performed well, particularly due to strong demand growth in the terminal market for medical consumables [1] - The optimistic market outlook for drug-device combination intelligent equipment led the company to focus on new product development and market expansion in this area, resulting in significant revenue growth from these products [1]